This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Fossil Stock Sinks 18% as Q3 Loss Widens Y/Y Amid DTC Weakness
by Zacks Equity Research
FOSL's Q3 loss widens year over year, pressured by direct-to-consumer weakness and store closures, while management reaffirmed full-year guidance and completed a key balance sheet restructuring.
The Zacks Analyst Blog Highlights Broadcom, Johnson & Johnson, Palantir Technologies, Fossil Group and Moving iMage
by Zacks Equity Research
Broadcom, Johnson & Johnson, and Palantir headline Zacks' latest analyst picks, with AI growth, pharma innovation, and defense tech momentum driving their outlooks.
Top Analyst Reports for Broadcom, Johnson & Johnson and Palantir
by Mark Vickery
Broadcom's AI surge, J&J's resilient growth, and Palantir's defense-driven momentum headline today's top analyst reports.
Fossil Climbs 62% Year to Date: Should You Buy the Stock?
by Zacks Equity Research
FOSL gains momentum with stronger liquidity, cost efficiency, product innovation, and renewed brand appeal, driving profitability.
The Zacks Analyst Blog Highlights Amazon.com, Salesforce, Abbott Laboratories and Fossil Group
by Zacks Equity Research
Amazon, Salesforce, Abbott and Fossil Group show diverging trends as AI spending weighs on margins, healthcare pipelines expand, and retail turnarounds gain traction.
Top Research Reports for Amazon.com, Salesforce & Abbott
by Mark Vickery
Amazon posts strong Q2 gains across AWS, Prime and ads, but weak Q3 income guidance and AI costs drag shares lower.
FOSL Incurs Narrower Y/Y Loss in Q2, Lifts 2025 Outlook
by Zacks Equity Research
Fossil trims losses in Q2 2025 as margins improve and costs fall while raising its full-year outlook and securing a refinancing deal to bolster liquidity.
FOSL Upgraded to Outperform Amid Turnaround Plan, Margin Gains
by Zacks Equity Research
Fossil's rating upgrade reflects early success in its turnaround plan, improved margins and renewed brand energy.
The Zacks Analyst Blog Highlights Alphabet, Oracle, Shell, Fossil and ImmuCell
by Zacks Equity Research
GOOGL, ORCL, and SHEL show sector strength, while microcaps FOSL and ICCC surge on strategic shifts and rising profitability.
Top Research Reports for Alphabet, Oracle & Shell
by Mark Vickery
GOOGL, ORCL, and SHEL stand out with strong cloud, AI, and LNG tailwinds, despite macro and margin headwinds.